ASX - By Stock
|
BOT |
Re:
Ann: Positive BTX 1702 Phase 1b/2 Clinical Study for Rosacea
|
|
camviv
|
100 |
42K |
2 |
13/10/22 |
13/10/22 |
ASX - By Stock
|
100
|
42K
|
2
|
|
ASX - By Stock
|
BRV |
Re:
Ann: Scheme of Arrangement Implemented
|
|
camviv
|
6 |
3.3K |
0 |
26/09/22 |
26/09/22 |
ASX - By Stock
|
6
|
3.3K
|
0
|
|
ASX - By Stock
|
BRV |
Re:
Ann: Scheme of Arrangement Implemented
|
|
camviv
|
6 |
3.3K |
0 |
21/09/22 |
21/09/22 |
ASX - By Stock
|
6
|
3.3K
|
0
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Trading Halt
|
|
camviv
|
72 |
24K |
2 |
31/08/22 |
31/08/22 |
ASX - By Stock
|
72
|
24K
|
2
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
camviv
|
13K |
4.7M |
17 |
31/03/22 |
31/03/22 |
ASX - By Stock
|
13K
|
4.7M
|
17
|
|
ASX - By Stock
|
BOT |
Re:
28 Cent Club
|
|
camviv
|
230 |
94K |
6 |
24/03/22 |
24/03/22 |
ASX - By Stock
|
230
|
94K
|
6
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
camviv
|
8.9K |
3.3M |
8 |
31/01/22 |
31/01/22 |
ASX - By Stock
|
8.9K
|
3.3M
|
8
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
camviv
|
13K |
4.7M |
3 |
28/06/21 |
28/06/21 |
ASX - By Stock
|
13K
|
4.7M
|
3
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
camviv
|
8.9K |
3.3M |
11 |
10/06/21 |
10/06/21 |
ASX - By Stock
|
8.9K
|
3.3M
|
11
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
camviv
|
8.9K |
3.3M |
5 |
09/06/21 |
09/06/21 |
ASX - By Stock
|
8.9K
|
3.3M
|
5
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
camviv
|
8.9K |
3.3M |
6 |
26/04/21 |
26/04/21 |
ASX - By Stock
|
8.9K
|
3.3M
|
6
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
camviv
|
8.9K |
3.3M |
6 |
01/04/21 |
01/04/21 |
ASX - By Stock
|
8.9K
|
3.3M
|
6
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
camviv
|
8.9K |
3.3M |
8 |
01/04/21 |
01/04/21 |
ASX - By Stock
|
8.9K
|
3.3M
|
8
|
|
ASX - By Stock
|
BRV |
Re:
Ann: Update to Plant Design Option Study Results
|
|
camviv
|
3 |
1.4K |
1 |
31/03/21 |
31/03/21 |
ASX - By Stock
|
3
|
1.4K
|
1
|
|
ASX - By Stock
|
BOT |
Re:
Ann: BTX 1702 Rosacea Study Approval
|
|
camviv
|
101 |
33K |
3 |
31/03/21 |
31/03/21 |
ASX - By Stock
|
101
|
33K
|
3
|
|
ASX - By Stock
|
BOT |
Re:
Friend or Foe?
|
|
camviv
|
56 |
15K |
1 |
29/03/21 |
29/03/21 |
ASX - By Stock
|
56
|
15K
|
1
|
|
ASX - By Stock
|
BOT |
Re:
Friend or Foe?
|
|
camviv
|
56 |
15K |
3 |
29/03/21 |
29/03/21 |
ASX - By Stock
|
56
|
15K
|
3
|
|
ASX - By Stock
|
BOT |
Re:
Friend or Foe?
|
|
camviv
|
56 |
15K |
1 |
29/03/21 |
29/03/21 |
ASX - By Stock
|
56
|
15K
|
1
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
camviv
|
13K |
4.7M |
26 |
16/03/21 |
16/03/21 |
ASX - By Stock
|
13K
|
4.7M
|
26
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
camviv
|
8.9K |
3.3M |
2 |
15/03/21 |
15/03/21 |
ASX - By Stock
|
8.9K
|
3.3M
|
2
|
|
ASX - By Stock
|
BOT |
Re:
hope this is going to ring true.
|
|
camviv
|
11 |
5.6K |
8 |
12/03/21 |
12/03/21 |
ASX - By Stock
|
11
|
5.6K
|
8
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
camviv
|
8.9K |
3.3M |
7 |
11/03/21 |
11/03/21 |
ASX - By Stock
|
8.9K
|
3.3M
|
7
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix Expands Management Team
|
|
camviv
|
44 |
22K |
11 |
08/03/21 |
08/03/21 |
ASX - By Stock
|
44
|
22K
|
11
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
camviv
|
8.9K |
3.3M |
1 |
04/03/21 |
04/03/21 |
ASX - By Stock
|
8.9K
|
3.3M
|
1
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
camviv
|
8.9K |
3.3M |
2 |
04/03/21 |
04/03/21 |
ASX - By Stock
|
8.9K
|
3.3M
|
2
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
camviv
|
8.9K |
3.3M |
3 |
03/03/21 |
03/03/21 |
ASX - By Stock
|
8.9K
|
3.3M
|
3
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
camviv
|
8.9K |
3.3M |
3 |
03/03/21 |
03/03/21 |
ASX - By Stock
|
8.9K
|
3.3M
|
3
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
camviv
|
8.9K |
3.3M |
5 |
03/03/21 |
03/03/21 |
ASX - By Stock
|
8.9K
|
3.3M
|
5
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
camviv
|
8.9K |
3.3M |
6 |
01/03/21 |
01/03/21 |
ASX - By Stock
|
8.9K
|
3.3M
|
6
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix Expands Management Team
|
|
camviv
|
44 |
22K |
10 |
01/03/21 |
01/03/21 |
ASX - By Stock
|
44
|
22K
|
10
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Botanix Expands Management Team
|
|
camviv
|
44 |
22K |
26 |
01/03/21 |
01/03/21 |
ASX - By Stock
|
44
|
22K
|
26
|
|
ASX - By Stock
|
BRV |
Re:
BRVDC - thought?
|
|
camviv
|
38 |
8.5K |
1 |
25/02/21 |
25/02/21 |
ASX - By Stock
|
38
|
8.5K
|
1
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
camviv
|
8.9K |
3.3M |
2 |
23/02/21 |
23/02/21 |
ASX - By Stock
|
8.9K
|
3.3M
|
2
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
camviv
|
8.9K |
3.3M |
3 |
23/02/21 |
23/02/21 |
ASX - By Stock
|
8.9K
|
3.3M
|
3
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
camviv
|
8.9K |
3.3M |
35 |
17/02/21 |
17/02/21 |
ASX - By Stock
|
8.9K
|
3.3M
|
35
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
camviv
|
8.9K |
3.3M |
14 |
17/02/21 |
17/02/21 |
ASX - By Stock
|
8.9K
|
3.3M
|
14
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
camviv
|
1K |
291K |
3 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
1K
|
291K
|
3
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
camviv
|
1K |
291K |
10 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
1K
|
291K
|
10
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
camviv
|
1K |
291K |
10 |
09/02/21 |
09/02/21 |
ASX - By Stock
|
1K
|
291K
|
10
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
camviv
|
1K |
291K |
5 |
08/02/21 |
08/02/21 |
ASX - By Stock
|
1K
|
291K
|
5
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
camviv
|
1K |
291K |
2 |
08/02/21 |
08/02/21 |
ASX - By Stock
|
1K
|
291K
|
2
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
camviv
|
1K |
291K |
3 |
05/02/21 |
05/02/21 |
ASX - By Stock
|
1K
|
291K
|
3
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
camviv
|
1K |
291K |
6 |
04/02/21 |
04/02/21 |
ASX - By Stock
|
1K
|
291K
|
6
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
camviv
|
13K |
4.7M |
4 |
04/02/21 |
04/02/21 |
ASX - By Stock
|
13K
|
4.7M
|
4
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
camviv
|
1K |
291K |
5 |
03/02/21 |
03/02/21 |
ASX - By Stock
|
1K
|
291K
|
5
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
camviv
|
1K |
291K |
4 |
03/02/21 |
03/02/21 |
ASX - By Stock
|
1K
|
291K
|
4
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
camviv
|
1K |
291K |
1 |
03/02/21 |
03/02/21 |
ASX - By Stock
|
1K
|
291K
|
1
|
|
ASX - By Stock
|
BOT |
Re:
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
|
|
camviv
|
1K |
291K |
5 |
03/02/21 |
03/02/21 |
ASX - By Stock
|
1K
|
291K
|
5
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
camviv
|
8.9K |
3.3M |
4 |
28/01/21 |
28/01/21 |
ASX - By Stock
|
8.9K
|
3.3M
|
4
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
camviv
|
8.9K |
3.3M |
0 |
27/01/21 |
27/01/21 |
ASX - By Stock
|
8.9K
|
3.3M
|
0
|
|